Summary
This paper discusses the therapeutic and adverse effects of Mucuna pruriens extract in the 6-OHDA rat model of Parkinson’s disease.
Categories
Dementia: The paper discusses Parkinson's disease, a type of dementia, and the effects of Mucuna pruriens extract on it.
Cognitive function and memory: The paper discusses the effects of Mucuna pruriens extract on Parkinson's disease, which affects cognitive function and memory.
Aging: The paper discusses Parkinson's disease, a condition that primarily affects older individuals.
Author(s)
JB Gramsbergen, M Jørgensen
Publication Year
2011
Related Publications
Dementia
- Photoreception for circadian, neuroendocrine, and neurobehavioral regulation
- New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
- Sleep and circadian rhythms in Parkinson's disease and preclinical models
- Chronobioengineering indoor lighting to enhance facilities for ageing and Alzheimer's disorder
- The effects of light and the circadian system on rhythmic brain function
Cognitive function and memory
- Phototransduction by retinal ganglion cells that set the circadian clock
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Information processing in the primate retina: circuitry and coding
- Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function
Aging
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges ahead
- Combinatorial effects of alpha-and gamma-protocadherins on neuronal survival and dendritic self-avoidance